Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
5.00
23.45
469.00%
Share Warrants & Outstandings
Total Reserve
107.51
1.97
105.54
5,357.36%
Shareholder's Funds
138.48
6.97
131.51
1,886.80%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
2.62
-0.63
-24.05%
Secured Loans
1.99
1.51
0.48
31.79%
Unsecured Loans
0.00
1.11
-1.11
-100.00%
Deferred Tax Assets / Liabilities
0.92
-0.07
0.99
1,414.29%
Other Long Term Liabilities
0.00
0.25
-0.25
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.91
2.80
0.11
3.93%
Current Liabilities
Trade Payables
102.54
1.31
101.23
7,727.48%
Other Current Liabilities
11.07
3.04
8.03
264.14%
Short Term Borrowings
32.87
7.74
25.13
324.68%
Short Term Provisions
2.73
0.00
2.73
0.00%
Total Current Liabilities
149.21
12.08
137.13
1,135.18%
Total Liabilities
290.59
21.85
268.74
1,229.93%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
1.86
37.24
2,002.15%
Less: Accumulated Depreciation
22.88
0.87
22.01
2,529.89%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
0.99
15.23
1,538.38%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
0.00
2.12
0.00%
Long Term Loans & Advances
6.64
0.00
6.64
0.00%
Other Non Current Assets
0.01
1.12
-1.11
-99.11%
Total Non-Current Assets
24.98
2.11
22.87
1,083.89%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
7.06
38.42
544.19%
Sundry Debtors
133.46
5.64
127.82
2,266.31%
Cash and Bank
1.47
5.21
-3.74
-71.79%
Other Current Assets
0.78
0.00
0.78
0.00%
Short Term Loans and Advances
84.41
1.82
82.59
4,537.91%
Total Current Assets
265.61
19.74
245.87
1,245.54%
Net Current Assets (Including Current Investments)
116.40
7.65
108.75
1,421.57%
Total Current Assets Excluding Current Investments
265.61
19.74
245.87
1,245.54%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
21.85
268.74
1,229.93%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
34.86
10.36
24.50
236.49%
Book Value per share (adjusted)
46.90
13.93
32.97
236.68%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






